dr. wakelee on the avaperl trial
Published 10 years ago • 60 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
0:55
dr. heather wakelee discusses the avaperl trial
-
2:18
dr. wakelee on first trial to combine antiangiogenesis agents with immunotherapy in nsclc
-
1:19
dr. wakelee on combining targeted agents for the treatment of lung cancer
-
1:32
dr. wakelee on immunotherapy versus targeted agents in nsclc
-
1:29
dr. wakelee on available treatments following tumor progression in lung cancer
-
20:04
dr. colin champ - dietary recommendations for cancer/warburg metabolism
-
2:02
adult stem cell bladder regeneration -- dr. anthony atala, wake forest university
-
3:20
#cancercare | lilavati hospital | mumbai
-
2:21
dr. wakelee on the rationale for immunotherapy in nsclc
-
1:36
dr. heather wakelee on what to do when resistance to egfr tkis emerges
-
1:35
dr. wakelee discusses maintenance therapy for patients with lung cancer
-
35:38
binaytara foundation_dr. heather wakelee on non-small cell lung cancer
-
1:35
dr. wakelee on unmet needs for immunotherapy in nsclc
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
1:16
dr. wakelee on first-line therapy for egfr-mutant lung cancer
-
1:40
dr. wakelee on immediate therapy options in lung cancer
-
1:33
dr. wakelee on continued maintenance in lung cancer
-
2:15
dr. wakelee on birch trial for atezolizumab in patients with nsclc
-
17:16
gracecast-028_lung-cancer_heather wakelee on nsclc adjuvant therapy
-
2:03
dr. wakelee on rationale to explore osimertinib with concurrent chemotherapy in egfr-mutant nsclc
-
1:23
dr. wakelee discusses current state of treatment in nsclc
-
1:01:37
frontiers in oncology - heather wakelee, md